Casper Breum

Biography

Casper joined Lundbeckfond Ventures when established, in late 2009. He is a member of the board of directors of Laboratoris Sanifit, Spero Therapeutics, Atox Bio, Biom’Up, and Dysis Medical. Previously he was a board member of Asante Solutions, Nexstim, and as employee representative at the boards of the Lundbeck Foundation and Lundbeckfond Invest A/S. Prior to joining Lundbeckfond Ventures, Casper most recently served as CEO of ilochip A/S, a venture backed company focused on development of diagnostic biochips. Before this, he spent eight years in different positions at H. Lundbeck A/S, including as a project manager and most recently in corporate business development and strategy, where he was responsible for negotiation of late stage licensing and M&A deals, and the related alliance management. Prior to his work at H. Lundbeck, Casper worked for Niels Clauson-Kaas A/S for five years where he was an R&D chemist and project manager and for Novo Nordisk A/S for three years where he was responsible for the development QA activities (CNS). Casper earned his MS in organic chemistry and an MBA, both at the Technical University of Denmark.

Research Interest

Genetics